← Back to Search

Anti-infective Agent

Hiprex for Recurring Urinary Tract Infections

Phase 4
Recruiting
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 50 - 85
Female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

This trial will test whether Hiprex, which contains formaldehyde, can help reduce the number of recurrent urinary tract infections in women.

Who is the study for?
This trial is for women aged 50-85 who have had at least two urinary tract infections in the last six months or three in the past year. They must be able to take Hiprex at home and speak English. Women with liver disease, allergies to Hiprex, uncontrolled diabetes, chronic renal failure, or those on antibiotics are excluded.Check my eligibility
What is being tested?
The study tests how effective Methenamine Hippurate (Hiprex) is for women with recurring UTIs by measuring formaldehyde levels in urine and observing if it reduces infection rates over time when taken under proper conditions.See study design
What are the potential side effects?
Possible side effects of taking Hiprex may include digestive issues like nausea or upset stomach, allergic reactions for those sensitive to its ingredients, and less commonly changes in urine color.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 85 years old.
Select...
I am female.
Select...
I have had at least 2 UTIs in the last 6 months or 3 in the last year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Urinary Tract Infections
Secondary outcome measures
Duration of intervals between UTI episodes
Number of adverse events related to Hiprex
Number of hospital re-admissions
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Group 1 - Patients with negative and positive urine cultureExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,043 Previous Clinical Trials
1,053,530 Total Patients Enrolled

Media Library

Hiprex (Anti-infective Agent) Clinical Trial Eligibility Overview. Trial Name: NCT04709601 — Phase 4
Urinary Tract Infection Research Study Groups: Group 1 - Patients with negative and positive urine culture
Urinary Tract Infection Clinical Trial 2023: Hiprex Highlights & Side Effects. Trial Name: NCT04709601 — Phase 4
Hiprex (Anti-infective Agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04709601 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Hiprex obtained authorization from the FDA?

"As Hiprex has already been approved, its safety rating is 3 on a scale of 1 to 3. This indicates that it has gone through numerous clinical trials and the results have demonstrated efficacy."

Answered by AI

What is the total enrollment count for this clinical research?

"Affirmative. Clinicaltrials.gov hosts the evidence that this clinical trial is presently recruiting participants, with the first post date of April 1st 2021 and latest update on July 6th 2022. The study necessitates 20 patients from one medical centre for enrolment."

Answered by AI

Is it possible to participate in this medical trial if one is over forty years of age?

"This clinical trial has age restrictions, requiring all participants to be at least 50 years old and no more than 85."

Answered by AI

Are there any prior experiments involving Hiprex that have been conducted?

"Presently, only one study is in progress that uses Hiprex as a research subject and it has yet to reach its third phase. With the majority of trials for this medication occurring within Dallas, TX; there is still another location running examinations on Hiprex."

Answered by AI

Are there still opportunities for enrollment in this experiment?

"Affirmative, details on clinicaltrials.gov reveal that this research is actively recruiting participants. It was initially posted on April 1st 2021 and most recently updated on July 6th 2022; 20 individuals must be recruited at one facility."

Answered by AI

To what criteria must individuals comply in order to qualify for this clinical trial?

"This clinical trial seeks 20 females aged between 50-85 who have had a minimum of two urinary tract infections (UTIs) in the past 6 months, or three UTIs within the last year."

Answered by AI
~3 spots leftby Dec 2024